Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Receivables (2019 - 2025)

Akso Health (AHG) has disclosed Receivables for 7 consecutive years, with $8.6 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Receivables rose 10.99% year-over-year to $8.6 million, compared with a TTM value of $8.6 million through Mar 2025, up 10.99%, and an annual FY2025 reading of $8.6 million, up 10.99% over the prior year.
  • Receivables was $8.6 million for Q1 2025 at Akso Health, up from $7.8 million in the prior quarter.
  • Across five years, Receivables topped out at $40.0 million in Q1 2022 and bottomed at $107972.0 in Q1 2021.
  • Average Receivables over 5 years is $11.9 million, with a median of $7.8 million recorded in 2024.
  • The sharpest move saw Receivables crashed 99.54% in 2021, then soared 36946.64% in 2022.
  • Year by year, Receivables stood at $107972.0 in 2021, then skyrocketed by 36946.64% to $40.0 million in 2022, then tumbled by 92.36% to $3.1 million in 2023, then soared by 154.12% to $7.8 million in 2024, then grew by 10.99% to $8.6 million in 2025.
  • Business Quant data shows Receivables for AHG at $8.6 million in Q1 2025, $7.8 million in Q1 2024, and $3.1 million in Q1 2023.